Emerging World Valuation
| EWPI Stock | USD 0.0001 0.00 0.00% |
Emerging World seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Emerging World Pharma from reviewing the firm fundamentals such as Net Income of (410.32 K), current ratio of 0.05 X, and Total Debt of 3.2 M as well as analyzing its technical indicators and probability of bankruptcy.
Enterprise Value 2.1 M |
Overvalued
Today
Please note that Emerging World's price fluctuation is very steady at this time. Calculation of the real value of Emerging World Pharma is based on 3 months time horizon. Increasing Emerging World's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Emerging World is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emerging Stock. However, Emerging World's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of Emerging World's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Emerging World's stock price.
Estimating the potential upside or downside of Emerging World Pharma helps investors to forecast how Emerging stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emerging World more accurately as focusing exclusively on Emerging World's fundamentals will not take into account other important factors: Emerging World Cash |
|
About Emerging World Valuation
An absolute valuation paradigm, as applied to Emerging Stock, attempts to find the value of Emerging World Pharma based on its fundamental and basic technical indicators. By analyzing Emerging World's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Emerging World's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Emerging World. We calculate exposure to Emerging World's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Emerging World's related companies.Complementary Tools for Emerging Stock analysis
When running Emerging World's price analysis, check to measure Emerging World's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emerging World is operating at the current time. Most of Emerging World's value examination focuses on studying past and present price action to predict the probability of Emerging World's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emerging World's price. Additionally, you may evaluate how the addition of Emerging World to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |